Trial intelligence / Profile preview

Comparison of IM and IV ACTH Stimulation Test in Healthy Volunteers

NCT03752190Phase 4Withdrawn

Sponsor
Johns Hopkins University
Start
Jul 2019
Primary completion
Sep 2020
Modality
Peptides, Small Molecules
01

Overview

A Phase 4 trial of tetracosactide hexaacetate in adrenal insufficiency (AI), sponsored by Johns Hopkins University. Planned start Jul 2019; status: withdrawn.

02

Drugs

tetracosactide hexaacetate
03

Conditions

adrenal insufficiency (AI)

Beyond the preview

Go deeper on NCT03752190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03752190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call